NOV 15, 2018 02:17 PM PST

Anti-inflammatory Drug Works Like an Inhibitor

WRITTEN BY: Nouran Amin

At Karolinska Institutet in Sweden, a team of scientists from multiple disciplines have worked together to develop an inflammation inhibitor.

Credit: The Scientist

The new anti-inflammatory drug molecule possess a unique mechanism of action. Essentially, the drug works by inhibiting a certain protein, called OGG1, which is studied to repair DNA was found to cause a reduction in the signals that trigger an inflammation.

The inhibitor works by blocking the release of inflammatory proteins, such as TNF alpha. During investigations on mice with acute pulmonary disease, the drug was found to dampen the inflammation.

Learn more about inflammatory responses:

In collaboration with the University of Texas Medical Branch, Uppsala University and Stockholm University--results of the findings are described in a publication in Science.

"We've developed a new drug molecule that inhibits inflammation," explains co-leader of the study, Professor Thomas Helleday, at the Department of Oncology-Pathology, Karolinska Institutet, Sweden. "It acts on a protein that we believe is a general mechanism for how inflammation arises in cells."

Discovery of the anti-inflammatory drug was the product of a long-term investigation on the mechanisms behind DNA repair—with the objective of fighting cancer by targeting a tumors cell’s DNA. Such research has resulted in several breakthrough drug discoveries including PARP inhibitors for the treatment of congenital breast and ovarian cancer.

Researchers were originally investigating the development of a new molecule that inhibits the enzyme, OGG1, which was found to be responsible for oxygen damage to DNA—that’s when they discovered that the molecule also dampened inflammation.

The result concluded that OGG1, apart from repairing DNA, triggers inflammation—making its inhibition critical in the treatment for inflammatory diseases.

"This discovery could give rise to a new treatment for a very serious condition," says Professor Helleday. "We'll now be developing our OGG1 inhibitor and examining whether it can lead to new treatments for inflammatory diseases in order to cure or relieve diseases such as sepsis, COPD and severe asthma."

Source: Science Magazine

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Combination Therapy for Advanced Melonoma
According to a research study led by UCLA, a bacteria-like agent used in combination with an immunotherapeutic drug may help patients survive longer with a...
SEP 08, 2018
Drug Discovery
SEP 08, 2018
Protein Associated With ALS Inspires Drug Treatments
Neurodegenerative diseases, such as degenerative ataxia or amyotrophic lateral sclerosis (ALS), will progressively cause an affected individual to develop ...
OCT 02, 2018
Drug Discovery
OCT 02, 2018
Compound Found In Fruits and Vegetables May Be The Next Anti-Aging Drug
According to early research published in Nature Medicine, it was found possible to increase the longevity of damaged cells, extend the lifespan, and improv...
NOV 10, 2018
Genetics & Genomics
NOV 10, 2018
Scientists Engineer a Better Way to Direct Evolution
Directed evolution is a Nobel-prize winning technique that has now been simplified and accelerated....
NOV 15, 2018
Drug Discovery
NOV 15, 2018
Making Cancer Disappear?
Neuroblastoma is one of the most common childhood cancers and the leading cause of cancer deaths among pediatric patients younger than 5. The cancer is fre...
DEC 11, 2018
Cancer
DEC 11, 2018
FDA approves two new drugs for cancers with specific genetic mutations
Last month the FDA approved two new drugs for cancer, both drugs target cancers with specific genetic mutations which made geneticists and oncologists optimistic on the future of cancer thera...
Loading Comments...